CYP1A2 rs2069514: What Your Genotype Means
The rs2069514 variant is a genetic change located within the CYP1A2 gene, which encodes an enzyme responsible for metabolizing various drugs and compounds. Research has investigated its potential association with the metabolism of substances like caffeine, though the clinical significance of this specific variant remains a subject of ongoing study.
What each genotype means
Rapid enzyme activity
This genotype is associated with higher CYP1A2 enzyme inducibility, which may lead to faster metabolism of certain drugs and compounds like caffeine. Research suggests this may influence individual responses to medications metabolized by this enzyme. Please discuss any medication dosing or potential side effects with your clinician or pharmacist.
This genotype is common in many global populations, though exact frequencies vary significantly by ancestry.
Intermediate enzyme activity
This genotype represents a heterozygous state that may result in intermediate CYP1A2 enzyme activity compared to homozygous individuals. The functional impact on drug metabolism can be variable and may depend on other genetic or environmental factors. Please discuss any medication dosing or potential side effects with your clinician or pharmacist.
This genotype is frequently observed across diverse populations worldwide.
Slower enzyme activity
This genotype is often associated with lower CYP1A2 enzyme inducibility, which may result in slower metabolism of specific substrates like caffeine or certain medications. Some studies suggest this may influence blood pressure responses to caffeine or the clearance of drugs. Please discuss any medication dosing or potential side effects with your clinician or pharmacist.
This genotype is common and found in a significant portion of the population across various ancestries.
Understanding the rs2069514 Variant
The rs2069514 variant is a single nucleotide polymorphism (SNP) found within the CYP1A2 gene. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in a region of the genome that influences how the CYP1A2 enzyme is produced or regulated. Because the CYP1A2 enzyme is a critical component of the body's detoxification and metabolic pathways, researchers often study variants like rs2069514 to determine if they contribute to differences in how people process medications, dietary compounds, and environmental toxins. While it is cataloged as a common variant, its presence does not inherently indicate a health condition, but rather a natural variation in the human genetic code that may influence biochemical processes.
The Role of the CYP1A2 Gene
The CYP1A2 gene provides instructions for making a member of the cytochrome P450 family of enzymes. These enzymes are primarily located in the liver and are essential for the oxidative biotransformation of a wide array of substances. CYP1A2 is specifically involved in metabolizing many clinically relevant drugs, including certain antidepressants, antipsychotics, and other psychotropic medications. Beyond pharmaceuticals, this enzyme also plays a role in the metabolism of endogenous compounds like steroids and dietary components such as caffeine. Because the activity level of this enzyme can vary between individuals due to genetic factors, environmental influences, and lifestyle habits like smoking, the CYP1A2 gene is a frequent focus in pharmacogenomics—the study of how genes affect a person's response to drugs. Understanding these variations is a key area of interest for optimizing therapeutic outcomes.
Research Associations and Evidence
Scientific research has explored the association between rs2069514 and the metabolism of various substrates, most notably caffeine. Some studies have suggested that specific genotypes at this locus may correlate with differences in the rate at which caffeine is broken down in the body. However, the evidence strength for this variant is generally considered moderate. While some studies report statistically significant associations in specific populations, other research has yielded mixed or inconclusive results. It is important to note that drug metabolism is a complex process influenced by multiple genes, environmental factors, and individual health status. Consequently, a single SNP like rs2069514 rarely acts in isolation. Current literature emphasizes that while genetic markers provide valuable insights into biological variability, they should be interpreted within the broader context of clinical data and professional medical guidance.
Population Frequency
The rs2069514 variant is considered common across diverse human populations. Genetic databases indicate that the alleles associated with this SNP are present at varying frequencies globally, reflecting the natural diversity of the human genome. Because it is a common variant, many individuals carry one or more copies of the different alleles. These frequencies can differ significantly between ancestral groups, which is a standard observation in population genetics. Researchers use this data to better understand the distribution of genetic traits and to ensure that pharmacogenomic studies account for ancestral diversity. While the frequency is well-documented in large-scale sequencing projects, the functional impact of these frequencies continues to be refined as more data becomes available from global cohorts.
Interpreting Your Genetic Information
Information regarding genetic variants like rs2069514 is intended for educational purposes and should not be used to make personal medical decisions. If you have concerns about how your body processes medications or how a specific genotype might affect your health, it is essential to consult with a qualified healthcare provider or a pharmacist. They can interpret genetic information in the context of your full medical history, current medications, and lifestyle factors. You should never change your medication dosage or discontinue a treatment based on genetic test results without professional supervision. Genetic testing can offer a window into your biological predispositions, but it is only one piece of a much larger puzzle. Always prioritize evidence-based clinical advice when managing your health and wellness.
How common is this variant?
The rs2069514 variant is common across global populations, with allele frequencies varying by ancestry as documented in large-scale genomic databases.
Frequently asked questions
Does rs2069514 mean I am a slow metabolizer?
Not necessarily. While some studies suggest associations between this variant and metabolic rates, it is not a definitive diagnostic tool for determining your overall drug metabolism speed.
Can I use this information to change my medication?
No. You should never alter your medication regimen based on genetic test results. Always discuss any concerns about drug response with your doctor or pharmacist.
Is rs2069514 the only variant that affects CYP1A2?
No, the CYP1A2 gene has many different variants. Drug metabolism is a complex process influenced by multiple genetic factors, environmental exposures, and lifestyle choices.
Where can I find more information about my specific results?
If you have received genetic testing results, consult the report provided by your testing service or speak with a genetic counselor who can explain the findings in the context of your health.
Sources & further reading
Educational information only, last refreshed 10/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2069514?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CYP1A2
This variant in the CYP1A2 gene influences the hepatic metabolism rate of caffeine and is a key marker for individual differences in caffeine clearance.
Intronic marker associated with CYP1A2 enzyme activity and caffeine metabolism rates.
Modulates CYP1A2 inducibility affecting the rate of caffeine metabolism and clearance.
Regulatory variant associated with CYP1A2 enzyme activity, influencing the rate of caffeine metabolism and habitual coffee consumption.
A common variant in the CYP1A2 gene associated with caffeine metabolism rates.
Located in intron 1 of CYP1A2, this variant modulates inducible enzyme activity, altering systemic caffeine clearance and individual susceptibility to caffeine-related blood pressure increases.